Related references
Note: Only part of the references are listed.Diagnosis and Staging of Chronic Graft-versus-Host Disease in the Clinical Practice
Hildegard T. Greinix et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
Daniel Wolff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Large pericardial effusion as a complication in adults undergoing SCT
M. Norkin et al.
BONE MARROW TRANSPLANTATION (2011)
Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD
Daniel Wolff et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Specific self-antigen-driven immune response in pericardial effusion as an isolated GVHD manifestation
A. Lev et al.
BONE MARROW TRANSPLANTATION (2010)
Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease
Oliver Grauer et al.
BRAIN (2010)
Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients
V. Brazzelli et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
Leonardo Magro et al.
BLOOD (2009)
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
Attilio Olivieri et al.
BLOOD (2009)
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT
K. Oda et al.
BONE MARROW TRANSPLANTATION (2009)
Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD
D. A. Jacobsohn et al.
BONE MARROW TRANSPLANTATION (2009)
Ultraviolet radiation and immunosuppression
G. M. Murphy
BRITISH JOURNAL OF DERMATOLOGY (2009)
Antipruritic efficacy of a high-dosage antihistamine therapy
S. Schulz et al.
HAUTARZT (2009)
Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil
Andreas Ambach et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)
Ancillary and supportive care in chronic graft-versus-host disease
Daniel R. Couriel
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells
Erin Gatza et al.
BLOOD (2008)
Penile lichen sclerosus after allogeneic stem cell transplantation
W-Y. Au et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease
J. B. Kim et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2008)
MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease
M. Horger et al.
SKELETAL RADIOLOGY (2008)
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation
Pamela Stratton et al.
OBSTETRICS AND GYNECOLOGY (2007)
Treatment of refractory chronic GVHD with rituximab: a GITMO study
F. Zaja et al.
BONE MARROW TRANSPLANTATION (2007)
Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease
S. Prot-Labarthe et al.
BONE MARROW TRANSPLANTATION (2007)
The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis
Uwe Wollina
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2007)
Genital graft-versus-host disease in a male following allogeneic stem cell transplantation
Elisabet Nylander et al.
ACTA DERMATO-VENEREOLOGICA (2007)
Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease
Davide Conrotto et al.
TRANSPLANTATION (2006)
Quality of life associated with acute and chronic graft-versus-host disease
S. J. Lee et al.
BONE MARROW TRANSPLANTATION (2006)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
Ancillary therapy and supportive care of chronic graft-versus-host disease:: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease:: V.: Ancillary Therapy and Supportive Care Working Group report
D Couriel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report
SZ Pavletic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease
DL Neuman et al.
BONE MARROW TRANSPLANTATION (2005)
Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease
M Robin et al.
TRANSPLANTATION (2005)
Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
L Giaccone et al.
BONE MARROW TRANSPLANTATION (2005)
Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus
T Schmook et al.
BONE MARROW TRANSPLANTATION (2005)
Pericardial graft vs. host disease in a patient with myelodysplastic syndrome following peripheral blood stem cell transplantation
Y Saito et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors
FM Foss et al.
BONE MARROW TRANSPLANTATION (2005)
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin
T Wetzig et al.
BONE MARROW TRANSPLANTATION (2005)
MRI for diagnosis and monitoring of patients with eosinophilic fasciitis
F Baumann et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease
P Sbano et al.
BONE MARROW TRANSPLANTATION (2004)
Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: Improvement of skin lesions, joint mobility, and quality of life
M Ziemer et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Treatment of extensive chronic cutaneous graftversus-host disease in an infant with topical pimecrolimus
M Ziemer et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation
C Messina et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis
C Romano et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia
L Law et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Psoralen plus ultraviolet-A-bath photochemotherapy as an a adjunct treatment modality in cutaneous chronic graft versus host disease
U Leiter et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2002)
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
SJ Lee et al.
BLOOD (2002)
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias
M Goerner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
The risk of melanoma in association with long-term exposure to PUVA
RS Stern
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA(1) phototherapy
M Grundmann-Kollmann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Share Paper
